Publicação: Losartan (DUR-753) blocks the natriuretic, kaliuretic and antidiuretic effect of intracerebroventricular injection of carbachol in water-loaded rats
Carregando...
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
Tipo
Artigo
Direito de acesso
Resumo
We determined the effect of intracerebroventricular (icv) administration of losartan, an angiotensin II (ANG II) subtype 1 receptor (AT1) antagonist, on icv carbachol-induced natriuresis, kaliuresis and antidiuresis in water-loaded male Holtzman rats (250-300 g) with a cannula implanted into the lateral ventricle (LV). The rats were water loaded with 5% of their body weight by gavage twice, with the second gavage one hour after the first. Carbachol (2 nmol in 1 μl) was injected icv immediately after the second load. When losartan (DUP-753, 50 nmol in 1 μl) was administered icv, it was given 3 min before carbachol. Previous icv treatment with losartan significantly reduced the icv carbachol-induced natriuresis (324 ± 17 μEq/120 min), kaliuresis (103 ± 15 μEq/120min) and antidiuresis (13.5 ± 2.1 ml/120 min) compared to the effects of previous icv injection of saline (Na+ excretion = 498 ± 22 μEq/120 min; K+ excretion = 167 ± 20 μEq/120 min; urine volume = 5.2 ± 1.2 ml/120 min). These results, reported as means ± SEM for 12 rats in each group, are consistent with the hypothesis that AT1 subtype receptors participate in the regulation of body electrolyte balance.
Descrição
Palavras-chave
Angiotensin II, AT1 receptors, Carbachol, DUP-753, Electrolyte balance, Losartan
Idioma
Inglês
Como citar
Brazilian Journal of Medical and Biological Research, v. 29, n. 4, p. 511-513, 1996.
